Get familiar with evidence on these supplementsJanuary 31, 2020NeurologyMusculoskeletal DisordersMental Health
Down syndrome arthritis: Distinct from JIA and missed in the clinicJanuary 2, 2020Musculoskeletal Disorders
Tofacitinib improves disease activity in patients with polyarticular-course JIADecember 11, 2019Rare DiseasesMusculoskeletal Disorders
AVXS-101 may result in long-term motor improvements in SMANovember 18, 2019Rare DiseasesMusculoskeletal Disorders
Psoriasis risk rises with TNF inhibitor use in children with inflammatory disordersOctober 30, 2019DermatologyMusculoskeletal Disorders
CBD: What physicians need to know about itOctober 28, 2019Mental HealthNeurologyMusculoskeletal Disorders
Juvenile dermatomyositis derails growth and pubertal developmentSeptember 18, 2019Musculoskeletal DisordersRare DiseasesDermatology
Mechanism does not matter for second-line biologic choice in JIAJuly 19, 2019Musculoskeletal Disorders
Emapalumab produces major responses in macrophage activation syndromeJuly 9, 2019ImmunologyMusculoskeletal Disorders
Efforts toward producing CNO/CRMO classification criteria show first resultsJune 20, 2019Musculoskeletal DisordersRare Diseases
When adolescents visit the ED, 10% leave with an opioidMay 28, 2019Adolescent MedicineOpioid Resource CenterInjuriesMusculoskeletal Disorders
New JIA, JIA-associated uveitis guidelines address knowledge gapsMay 10, 2019Musculoskeletal Disorders
Opioids don’t top NSAIDs for chronic painDecember 20, 2018Opioid Resource CenterCardiologyMusculoskeletal DisordersObesityEndocrinologyBusiness of Medicine
